Serialization Readiness Checklist 2026 (L1–L5) Are you actually ready for serialization changes in 2026? Most pharma companies say they are. Very few have actually checked. Regulatory updates, new markets, system upgrades, partner changes - none of these test a single tool. They test the entire L1–L5 serialization setup. This...
Read More
Traceability of Medicines in Indonesia: Regulatory Requirements and Compliance Indonesia represents one of the most dynamic pharmaceutical markets in Southeast Asia. With a population of nearly 280 million and expanding access to healthcare, the market was valued at approximately USD 7–8 billion in 2020 and is...
Read More
Traceability of Medicines in Egypt: A Practical Guide to Serialization and Track & Trace Compliance In recent months, several pharmaceutical companies preparing exports to Egypt raised the same concern during readiness discussions: “We already serialize - are we actually compliant for Egypt?” In one case, a shipment...
Read More
Pharma Traceability Deadlines for 2026–2027: Your Complete Regulatory Roadmap Why 2026–2027 can’t be “just another year” 2026 will be one of the most demanding years for pharmaceutical traceability. New serialization, aggregation and reporting rules go live across multiple markets – within months, not years. Armenia, Egypt, Ethiopia, Guinea-Bissau, Rwanda...
Read More
Why Identity Security Matters in Pharma: Phishing, Privileges and Passwords in 2025 Digital identity is now the primary entry point for cyberattacks in the pharmaceutical industry. With production systems, serialization environments, and partner networks becoming increasingly interconnected, a single compromised account can disrupt entire operations and...
Read More
A Major Compliance Shift: Algeria Makes Serialization Mandatory On October 12, 2025, Algeria’s Ministry of Pharmaceutical Industry introduced a decisive regulatory step forward. The Ministerial Decree No. 25 (Arrêté N°25 du 12 Octobre 2025), published in the Official Journal of the Algerian Republic, now makes serialization...
Read More
Guinea-Bissau: Key Regulatory Deadlines and Requirements On 19 September 2025, the Government of Guinea-Bissau officially established its national pharmaceutical traceability system – the AVG Pharmaceutical Traceability Hub. The initiative was launched under Dispatch No. 31/GMSP/2025 and the Joint Dispatch of the General Health Inspection Office (IGAS) and...
Read More
Cybersecurity Risks in Pharma: Why Identity and Cloud Security Are Now Compliance Priorities Cyberattacks against manufacturing companies are growing in scale and precision. According to the IBM X-Force Threat Intelligence Index 2025, manufacturing remains the most targeted industry worldwide for the fourth year in a row. Attackers...
Read More
New SAHPRA Traceability Guideline Outlines Step-by-Step Implementation Roadmap The South African Health Products Regulatory Authority (SAHPRA) has published its official Traceability Guideline, defining a structured roadmap for introducing unique product identification and unit-level serialisation across all health products in South Africa. This marks a significant shift from...
Read More
Africa’s Road to Pharma Traceability: Updates from 2025 Onwards Counterfeit medicines remain one of the biggest health threats in Africa. The World Health Organization (WHO) estimates that the continent accounts for 42% of all falsified medicines worldwide, and in some low- and middle-income countries, 10% of...
Read More
Ukraine’s Potential Path to a National Medicines Verification System by 2028 Ukraine has taken a decisive step toward aligning its pharmaceutical supply chain with European Union standards. On 26 September 2024, the Cabinet of Ministers of Ukraine approved the creation of a national medicines verification system...
Read More
Egypt Pharma Serialization: Track & Trace Timeline and Market Insights (2026) Last updated: August 2025, with the latest rollout dates announced by the Egyptian Drug Authority (EDA). Earlier this month, the Egyptian Drug Authority officially announced in the Official Gazette the launch of Egypt’s unified national electronic...
Read More
Zimbabwe Serialization Update: What Pharma Companies Must Know On July 18th, Zimbabwe took an important step toward improving public health and combating counterfeit medicines by introducing new traceability guidelines for medical products. This targets pharmaceutical manufacturers, importers, exporters, distributors, and other relevant stakeholders. As a pharma company...
Read More
Shift Happens: Pharma Serialization Flexibility Without Compliance Risk Shift happens. It’s the unspoken reality of pharmaceutical manufacturing. Let’s be honest. Shift isn’t the only thing that happens - machines stop, specs change, reports are delayed. And compliance? That still has a deadline. Pharma production plans are often built months...
Read More
Paraguay Launches National Traceability System for Medicines and Medical Devices In April 2025, Paraguay took a significant step toward pharmaceutical supply chain modernization by launching the National System for the Traceability of Medicines and Medical Devices through Decree № 3668/25. This new regulation sets the foundation...
Read More
Production Planning Is Predictable. Operations Are Not. Pharmaceutical manufacturing is one of the most planned environments in the world yet it’s also one of the most unpredictable. Machines go offline. A marketing campaign spikes demand. A partner changes specs mid-batch. Suddenly, the production plan you finalized weeks...
Read More
New Traceability Rules in Ethiopia: What Pharma Exporters Must Do by 2026 The Ethiopian Food and Drug Authority (EFDA) is taking a major step forward in securing its pharmaceutical supply chain. With the launch of the EFDA-MVC Traceability Hub, Ethiopia is now enforcing traceability requirements for...
Read More
Italy’s FMD Timeline at a Glance Italy’s transition to full EU Hub integration is well structured and full of deadlines. Here’s the timeline all MAHs should track: Until Feb 2027: Stabilization period; use of the “bollino” still allowed October 2025: Italy connects to the EU Hub...
Read More
Snapshot: Greece’s Onboarding Progress Greece has made notable strides in FMD implementation. As of Q2 2025, the Hellenic Medicines Verification System (HMVS) has: 10,507 private pharmacies 135 public hospitals 148 wholesalers 91 private hospitals fully onboarded and scanning products. That’s 10,881 verified end-users integrated into the national...
Read More
Why EU Hub Product Data Quality Matters Good data doesn't mean only a good structure. It is much more than it. It’s a compliance, a traceability, and trust. The EMVS relies on accurate Product Master Data (PMD) and Product Pack Data (PPD) to protect patients and...
Read More